Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06445751 · ClinicalTrials.gov registry record · Phase 2
Step Up for STEM and Health Careers
A Phase 2 study, sponsored by Ohio State University.
- Terminated
- Registry status
- Phase 2
- Development phase
- 24
- Enrollment target
NCT06445751: Clinical Trial Phase 2 study, sponsored by Ohio State University.
NCT06445751 is a Phase 2 study that was terminated before completion, run by Ohio State University. The registered enrollment target is 24 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (82% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06445751, a Phase 2 study, was terminated before completion, sponsored by Ohio State University.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 24 participants
- Enrollment target
Study Summary
The goal of this randomized controlled trial is to evaluate "Step Up for STEM and Health Careers". The "Step Up for STEM and Health Careers" ("Step Up") game is an interactive, digital resource that includes the key elements of a bystander intervention for high school students to understand the importance of diversity in STEM; it also addresses skills, attitudes, and awareness to attain positive STEM identities and mitigate bias and harassment in STEM and health learning environments. Participants in the intervention arm will be asked to complete the Step Up interactive game; participants in the comparison group will be asked to view a PowerPoint presentation on bias and harassment in STEM/health fields as the control experience. The Step Up game intervention and study outcomes are theory-based (Theory of Planned Behavior, Social Cognitive Career Theory (SCCT)): we will assess the impact of Step Up on attitudes about STEM/health careers, STEM/health career self-efficacy, and bystander behavior.
Primary Outcome
One's beliefs about outcomes associated with STEM/health careers
Interventions
- BEHAVIORAL Step Up for STEM and Health Careers ("Step Up") game
- BEHAVIORAL Educational PowerPoint Presentation on Diversity in STEM Careers
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2024-07-02 |
| Est. Completion | 2025-03-21 |
| Phase | Phase 2 |
Why NCT06445751 stopped before completion
NCT06445751 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (82% lower).
The record links to 0 conditions, and to 2 interventions - of which Step Up for STEM and Health Careers ("Step Up") game is the first listed.
NCT06445751 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06445751 about?
NCT06445751 is a clinical study titled "Step Up for STEM and Health Careers". The goal of this randomized controlled trial is to evaluate "Step Up for STEM and Health Careers". The "Step Up for STEM and Health Careers" ("Step Up") game is an interactive, digital resource that includes the key elements of a bystander intervention for high school students to understand the impo...
What is the current status of trial NCT06445751?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 24 participants. The study started on 2024-07-02. Estimated completion is 2025-03-21.
What interventions are being tested in trial NCT06445751?
The interventions under investigation include: Step Up for STEM and Health Careers ("Step Up") game (BEHAVIORAL), Educational PowerPoint Presentation on Diversity in STEM Careers (BEHAVIORAL).
Who is sponsoring clinical trial NCT06445751?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06445751's enrollment target sits among peer trials
24 1756th of 2000 higher than 217 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI